These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 32064627)
1. Allergic contact dermatitis in response to ketotifen fumarate contained in eye drops. Romita P; Stingeni L; Barlusconi C; Hansel K; Foti C Contact Dermatitis; 2020 Jul; 83(1):35-37. PubMed ID: 32064627 [No Abstract] [Full Text] [Related]
2. Sensitization from ketotifen fumarate in eye drops presenting as chronic conjunctivitis. Smets K; Werbrouck J; Goossens A; Gilissen L Contact Dermatitis; 2017 Feb; 76(2):124-126. PubMed ID: 28095628 [No Abstract] [Full Text] [Related]
3. Ocular tolerability and safety of ketotifen fumarate ophthalmic solution. Abelson MB; Chapin MJ; Kapik BM; Shams NB Adv Ther; 2002; 19(4):161-9. PubMed ID: 12431041 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of single- and multiple-dose ketotifen fumarate 0.025% ophthalmic solution in a pediatric population. Abelson MB; Ferzola NJ; McWhirter CL; Crampton HJ Pediatr Allergy Immunol; 2004 Dec; 15(6):551-7. PubMed ID: 15610370 [TBL] [Abstract][Full Text] [Related]
5. A Subtle Historical Clue Unlocks a Contact Puzzle. DeBord L; Enos T; Cruz P Dermatitis; 2019; 30(1):77. PubMed ID: 30570572 [No Abstract] [Full Text] [Related]
6. Efficacy and safety of ketotifen eye drops in the treatment of seasonal allergic conjunctivitis. Kidd M; McKenzie SH; Steven I; Cooper C; Lanz R; Br J Ophthalmol; 2003 Oct; 87(10):1206-11. PubMed ID: 14507747 [TBL] [Abstract][Full Text] [Related]
7. Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial. Crampton HJ Clin Ther; 2003 Jul; 25(7):1975-87. PubMed ID: 12946545 [TBL] [Abstract][Full Text] [Related]
8. [Ketotifen fumarate (Zaditen) eye drops in the treatment of seasonal allergic conjunctivitis]. Haicl P; Cerná H Cesk Slov Oftalmol; 2004 Sep; 60(5):362-7. PubMed ID: 15566225 [TBL] [Abstract][Full Text] [Related]
9. Bioequivalence of two formulations of ketotifen fumarate ophthalmic solution: a single-center, randomized, double-masked conjunctival allergen challenge investigation in allergic conjunctivitis. Torkildsen GL; Abelson MB; Gomes PJ Clin Ther; 2008 Jul; 30(7):1272-82. PubMed ID: 18691986 [TBL] [Abstract][Full Text] [Related]
14. [Comparative study between 0.025% ketotifen fumarate and 0.1% olopatadine hydrochloride in the treatment of vernal keratoconjunctivitis]. Hida WT; Nogueira DC; Schaefer A; Dantas PE; Dantas MC Arq Bras Oftalmol; 2006; 69(6):851-6. PubMed ID: 17273679 [TBL] [Abstract][Full Text] [Related]
15. Ketotifen fumarate and olopatadine hydrochloride in the treatment of allergic conjunctivitis: a real-world comparison of efficacy and ocular comfort. Ganz M; Koll E; Gausche J; Detjen P; Orfan N Adv Ther; 2003; 20(2):79-91. PubMed ID: 12836808 [TBL] [Abstract][Full Text] [Related]
16. Periorbital Allergic Contact Dermatitis Due to Ketotifen. Aschenbeck KA; Warshaw EM Dermatitis; 2017; 28(2):164-165. PubMed ID: 28169851 [No Abstract] [Full Text] [Related]
17. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial. Avunduk AM; Tekelioglu Y; Turk A; Akyol N Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412 [TBL] [Abstract][Full Text] [Related]
18. Contact dermatitis to both tropicamide and phenylephrine eye drops. Haroun-Díaz E; Ruíz-García M; De Luxán de la Lastra S; Pastor-Vargas C; De las Heras M; Sastre Domínguez J; Cuesta-Herranz J Dermatitis; 2014; 25(3):149-50. PubMed ID: 24819290 [No Abstract] [Full Text] [Related]
19. Cyclosporine A eye drops inhibit the early-phase reaction in a type-I allergic conjunctivitis model in mice. Shii D; Oda T; Shinomiya K; Katsuta O; Nakamura M J Ocul Pharmacol Ther; 2009 Aug; 25(4):321-8. PubMed ID: 19650707 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and Tolerability of Ketotifen in the Treatment Of Seasonal Allergic Conjunctivitis: Comparison between Ketotifen 0.025% and 0.05% Eye Drops. Leonardi A; Capobianco D; Benedetti N; Capobianco A; Cavarzeran F; Scalora T; Modugno R; Feuerman OM Ocul Immunol Inflamm; 2019; 27(8):1352-1356. PubMed ID: 30303746 [No Abstract] [Full Text] [Related] [Next] [New Search]